Publikation

Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series.

Wissenschaftlicher Artikel/Review - 15.04.2022

Bereiche
PubMed
DOI
Kontakt

Zitation
Rüfenacht S, Gantenbein P, Boggian K, Flury D, Kern L, Dollenmaier G, Kohler P, Albrich W. Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series. Infection 2022; 50:783-790.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Infection 2022; 50
Veröffentlichungsdatum
15.04.2022
eISSN (Online)
1439-0973
Seiten
783-790
Kurzbeschreibung/Zielsetzung

COVID-19 patients on anti-CD20 treatment can suffer a delayed viral clearance and worse clinical outcome. We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trials are available.